ArticleDrug design, development and therapy2021

Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway.

Xinhui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.